Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof

Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof

US Patent 9084743 · Granted Jul 21, 2015

Estimated economic value: $13,519,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS2025
Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS2025
Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS2025
Stabilized liquid and lyophilized ADAMTS13 formulations2024
Anti-factor IX padua antibodies2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
Stabilized liquid and lyophilized ADAMTS13 formulations2023
Method to produce a highly concentrated immunoglobulin preparation for subcutane2022
Method to produce a highly concentrated immunoglobulin preparation for subcutane2022